###begin article-title 0
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 485 488 485 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 330 336 <span type="species:ncbi:9606">humans</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative disorders characterized by accumulation of autofluorescent material in many tissues, especially in neurons. Mutations in the CLN8 gene, encoding an endoplasmic reticulum (ER) transmembrane protein of unknown function, underlie NCL phenotypes in humans and mice. The human phenotype is characterized by epilepsy, progressive psychomotor deterioration and visual loss, while motor neuron degeneration (mnd) mice with a Cln8 mutation show progressive motor neuron dysfunction and retinal degeneration.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 631 636 631 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
We investigated spatial and temporal expression of Cln8 messenger ribonucleic acid (mRNA) using in situ hybridization, reverse transcriptase polymerase chain reaction (RT-PCR) and northern blotting. Cln8 is ubiquitously expressed at low levels in embryonic and adult tissues. In prenatal embryos Cln8 is most prominently expressed in the developing gastrointestinal tract, dorsal root ganglia (DRG) and brain. In postnatal brain the highest expression is in the cortex and hippocampus. Expression of Cln8 mRNA in the central nervous system (CNS) was also analyzed in the hippocampal electrical kindling model of epilepsy, in which Cln8 expression was rapidly up-regulated in hippocampal pyramidal and granular neurons.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
Expression of Cln8 in the developing and mature brain suggests roles for Cln8 in maturation, differentiation and supporting the survival of different neuronal populations. The relevance of Cln8 up-regulation in hippocampal neurons of kindled mice should be further explored.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 402 407 <span type="species:ncbi:10090">mouse</span>
###xml 452 457 <span type="species:ncbi:10090">mouse</span>
The neuronal ceroid lipofuscinoses (NCLs) comprise a group of human neurodegenerative disorders (CLN1-CLN8) characterized by epilepsy, visual failure, psychomotor deterioration and accumulation of autofluorescent lipopigment in many tissues, especially in neurons [1]. Six genes underlying human NCLs have been identified and the proteins initially characterized (reviewed in [2]). Naturally occurring mouse models exist for CLN6 and CLN8 [3-5], while mouse models for CLN1, CLN2 and CLN3 have been generated by gene targeting [6-10].
###end p 9
###begin p 10
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1136 1141 1136 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1206 1210 1206 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd </italic>
###xml 1255 1256 1255 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1326 1329 1326 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd</italic>
###xml 1420 1421 1420 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1422 1424 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1425 1427 1425 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1477 1478 1477 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1479 1481 1479 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1482 1484 1482 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1663 1667 1663 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd </italic>
###xml 1668 1670 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1671 1673 1671 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 261 267 <span type="species:ncbi:9606">humans</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
###xml 629 637 <span type="species:ncbi:9606">patients</span>
###xml 1130 1135 <span type="species:ncbi:10090">mouse</span>
###xml 1210 1215 <span type="species:ncbi:10090">mouse</span>
###xml 1242 1247 <span type="species:ncbi:10090">mouse</span>
###xml 1271 1276 <span type="species:ncbi:9606">human</span>
###xml 1277 1285 <span type="species:ncbi:9606">patients</span>
The ubiquitously expressed CLN8 gene encodes a transmembrane protein which localizes to the ER and the ER-Golgi intermediate compartment in non-neuronal cells and to the ER in neuronal cells [4,11,12]. Mutations in CLN8 result in two distinct NCL phenotypes in humans: Northern epilepsy (Progressive epilepsy with mental retardation, EPMR, OMIM 600143) described in Finnish patients, and variant late infantile onset NCL in a subset of Turkish patients [4,13]. EPMR is characterized by frequent drug-resistant epileptic seizures with onset at 5-10 years of age, followed by progressive mental retardation [14], while the Turkish patients show earlier onset and a more rapid progression [15]. In EPMR, intracellular storage material, including subunit c of the mitochonrdial ATP synthase as the main protein component, is most prominent in the CNS, especially in the third layer of the isocortex and hippocampal regions CA2-4 [16]. In the cerebral isocortex the pyramidal cells of the deeper parts of lamina III are severely ballooned, and hippocampal region CA2 shows neuronal loss and neuronophagy [16]. A frameshift mutation in mouse Cln8 that predicts a truncated protein underlies the phenotype of the mnd mouse, a naturally occuring NCL mouse model [4]. Contrary to human patients, epilepsy is not a prominent feature in mnd, which is characterized by progressive motor neuron dysfunction and retinal degeneration [5,17,18]. The brain appears to remain relatively intact [5,17,19]. Accumulation of subunit c of the mitochondrial ATP synthase, neurofilament redistribution in spinal motor neurons and accumulation of ubiquitin deposits are characteristic for mnd [20-22].
###end p 10
###begin p 11
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
Here we characterized the spatial and temporal expression of Cln8 mRNA in mice. Moreover, as epilepsy is the dominant phenotype in human patients, we investigated the CNS expression of Cln8 mRNA in the hippocampal electrical kindling model of epilepsy in which repeated electrical stimulations trigger a progressive intensification of epileptiform responses, and kindled mice retain abnormal excitability thereafter [23,24].
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
The Cln8 gene is ubiquitously expressed in mouse tissues
###end title 13
###begin p 14
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 648 653 <span type="species:ncbi:10090">mouse</span>
The expression of the Cln8 gene in mouse tissues was first analyzed by northern blot and real-time quantitative RT-PCR analyses. In northern blot analysis one ~3 kilobase (kb) Cln8 specific transcript was detected in all tissues analyzed including a 14-day embryo (E14) (Fig. 1A). In addition, one ~7 kb transcript was seen in all tissues except testis and heart (Fig. 1A). In spleen, an additional transcript of ~2 kb was detected (Fig. 1A). The ~7 kb and ~2 kb transcripts were notably weaker than the ~3 kb transcript. RT-PCR analysis covering the 867 bp open reading frame of Cln8 resulted in a single fragment of the same size in 12 different mouse tissues (data not shown), suggesting that the different transcripts detected in the northern analysis are not due to alternative splicing in the coding region.
###end p 14
###begin p 15
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
###xml 470 475 <span type="species:ncbi:10090">mouse</span>
We then estimated the level of Cln8 expression using real-time quantitative RT-PCR analysis. Cln8 showed highest expression in liver, spleen, heart and skeletal muscle, 2.5, 2.2, 1.7 and 1.6 fold higher (respectively) than in the brain (Fig. 1B). Expression was lowest in 11-day embryo and adult kidney, lung and testis, 0.6, 0.9, 0.5 and 0.03 fold lower than in the brain (Fig. 1B). This indicates that Cln8 expression levels in adult mouse tissues as well as in whole mouse embryos are not dramatically different.
###end p 15
###begin title 16
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Cln8 is expressed throughout mouse development
###end title 16
###begin p 17
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
The tissue expression of Cln8 during development and brain maturation was characterized using radioactive mRNA in situ hybridization analysis. For this purpose, whole embryo sections from E13, E15.5 and E17 mice and brain sections from postnatal (P) P0, P5, P10 and adult mice were used and the expression of Cln8 was quantitated by a computer based MCID image analysis system.
###end p 17
###begin p 18
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 174 180 174 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, 2B</xref>
###xml 247 253 247 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C, 2D</xref>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8</italic>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8</italic>
In fresh-frozen E13 and E17 embryos the overall expression of Cln8 was weak. In E17 the most prominent expression was detected in the developing gastrointestinal tract (Fig. 2A, 2B). In addition, there was high expression in the DRG neurons (Fig. 2C, 2D). Some Cln8-specific signal was also detected in the developing brain (Fig. 2E). The expression of Cln8 in E13 was similar to that in E17 except in the DRG neurons, where no signal was detected (data not shown). In paraffin-embedded E15.5 embryos a Cln8-specific signal was detected in the developing gastrointestinal tract, adrenal glands and the developing brain, especially in the cortical plate (data not shown).
###end p 18
###begin p 19
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 624 629 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 862 867 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
In postnatal mice (P0, P5, P10 and adult) Cln8 expression was quantitated in the cortex, cerebellum and different hippocampal regions. Expression at P0 was low but specific in hippocampal regions CA1, CA3 and the granular cell layer of the dentate gyrus and in the cortex (Fig. 3). At P5 and P10, the Cln8 expression increased in the hippocampal CA1 region (to 115% and 106% of P0) and especially in the CA3 region (to 139% of P0) (Fig. 3). In adult brain the expression levels of Cln8 were lower than at P0, P5 and P10 in every region analyzed (Fig. 3). When compared with adults, a statistically significant difference in Cln8 expression was detected in the cortex at P0, P5 and P10 and in the CA3 region at P10 (Fig. 3). Expression of Cln8 in adult cerebellum was 156% of expression in the cortex (data not shown). In all maturation stages, the expression of Cln8 was highest in hippocampal region CA3 (Fig. 3).
###end p 19
###begin title 20
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
Cln8 expression is strongly up-regulated in the hippocampal electrical kindling model of epilepsy
###end title 20
###begin p 21
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 732 737 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 808 809 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 882 883 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 914 919 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1068 1069 1062 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1110 1115 1104 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1270 1271 1264 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1341 1346 1335 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1506 1507 1500 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1525 1530 1519 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 864 869 <span type="species:ncbi:10090">mouse</span>
Epileptic seizures are a characteristic feature in human patients with CLN8 mutations. We therefore analyzed, by mRNA in situ hybridization analysis, possible changes in Cln8 expression 2 h, 6 h and 24 h after kindling-induced epileptic seizures. Animals were subjected to 40 rapid kindling stimulations which lead to increased excitability in mice at 4 weeks after the stimulation [25]. Each rapid kindling stimulation induced relatively short focal (grade 0-2) or long-lasting generalized (grade 4-5) seizures. The mean duration of afterdischarges was 20 +/- 3 s for focal seizures and 76 +/- 8 s for generalized seizures. All animals experienced multiple (11 +/- 2) grade 4-5 generalized tonic-clonic seizures. The expression of Cln8 in the control, electrode implanted but non-stimulated mice (0 h; Fig. 4) was essentially identical to that in wild-type adult mouse brain (Fig. 3). After kindling stimulations Cln8 was strongly up-regulated in the hippocampus, especially in the CA3 region and most prominently in the granular cell layer of the detate gyrus (Fig. 4). After 2 h, 6 h and 24 h expression of Cln8 in CA3 was 92%, 114% and 134% of that of controls, and in the granular cell layer of the dentate gyrus 128%, 225% and 286% of controls, respectively (Fig. 4). When compared to controls, a statistically significant increase in Cln8 expression was detected in the cortex after 6 h, and in the CA1 and CA3 regions, and the granular cell layer of the dentate gyrus after 2 h, 6 h and 24 h (Fig. 4). All changes in Cln8 mRNA expression after rapid kindling stimulations were bilateral with no differences between the sides.
###end p 21
###begin title 22
Discussion
###end title 22
###begin p 23
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8</italic>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 586 591 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 739 744 739 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8 </italic>
###xml 963 964 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1006 1010 1006 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN8</italic>
###xml 1011 1016 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1154 1159 1154 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1329 1334 1329 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1566 1570 1566 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd </italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:10090">mouse</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
###xml 690 695 <span type="species:ncbi:9606">human</span>
###xml 700 705 <span type="species:ncbi:10090">mouse</span>
###xml 946 951 <span type="species:ncbi:9606">human</span>
###xml 1553 1561 <span type="species:ncbi:9606">patients</span>
###xml 1570 1574 <span type="species:ncbi:10090">mice</span>
We analyzed the expression of the Cln8 gene during mouse development and in the hippocampal kindling model of epilepsy to gain understanding of the role of CLN8 in the disease mechanisms underlying both human and mouse NCLs. In northern blot analysis a Cln8 transcript of approximately 3 kb was detected in all tissues studied. Two additional transcripts, approximately 2 kb and 7 kb, were detected in several tissues. Thus, Cln8 expression resembles that of human CLN8, which is ubiquitously expressed with transcripts of 1.4 kb, 3.4 kb and 7.5 kb [4]. The open reading frame of mouse Cln8 is 82% identical with CLN8 and at the amino acid level the proteins are 85% identical [4]. In both human and mouse genes the RT-PCR analysis of the CLN8 open reading frame resulted in a single fragment, suggesting that the different size transcripts seen in northern analysis are due to alternative 3' untranslated regions as previously suggested for the human CLN8 gene [4]. It is, however, also possible that the CLN8/Cln8 genes have several transcription initiation sites. Real-time quantitative RT-PCR analysis further suggested that the expression levels of Cln8 are relatively low in both adult and embryonic tissues, and showed that expression levels in various tissues do not differ dramatically. The remarkably low expression of Cln8 in testis could reflect a high level of the control gene analyzed in this tissue. Despite ubiquitous expression of the underlying gene and accumulation of storage material in all tissues, the most severe damage in EPMR patients and mnd mice is in neuronal cells. This is also characteristic of other NCLs, suggesting that NCL proteins may have a specific function in neuronal cells distinct from the role in non-neuronal cells, or that certain neuronal populations may be more sensitive to the disturbed function of NCL proteins.
###end p 23
###begin p 24
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 757 761 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd </italic>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1212 1214 1212 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1306 1308 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1309 1311 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1573 1578 1573 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 1680 1685 1680 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 761 766 <span type="species:ncbi:10090">mouse</span>
###xml 817 822 <span type="species:ncbi:10090">mouse</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
In situ hybridization analysis of developing mice indicates that Cln8 mRNA is expressed throughout development as well as in the mature brain. The expression of Cln8 in embryonic stages E13 and E17 was specific but low in many tissues including brain, but remarkably high in the developing gastrointestinal tract. This may indicate a role for Cln8 in the innervation of the developing gut. In addition, in the E17 embryo Cln8 expression was high in DRG neurons. These neurons determine the connections between interneurons and motoneurons of the spinal cord. Assuming a role for Cln8 in this process, its disturbed function might result in defective connections in DRG with consecutive dysfunction of motor neurons resulting in progressive paralysis in the mnd mouse model [5,17]. The expression of Cln8 in postnatal mouse brain was highest at developmental stages P5 and P10, especially in hippocampal region CA3. The brain expression was clearly lower in adult mice than at P0, P5 and P10, suggesting a role for Cln8 in brain maturation. This early postnatal period is characterized by a rapid increase in the number of synapses, as well as maturation of oligodendrocytes, the myelin-forming cells in the CNS [26]. Two other NCL proteins, Ppt1 and Cln3, have been localized to synaptic areas of neurons [27,28] suggesting the importance of these NCL proteins for synaptic functions. However, detailed study of the function of Cln8 in the CNS and different brain cells is currently hampered by the lack of a specific antibody detecting endogenous Cln8. Very low levels of Cln8 mRNA were also detected in developing and adult motoneurons and retina (data not shown). However, the Cln8 transcript levels in these samples were virtually indistinguishable from the respective sense controls.
###end p 24
###begin p 25
###xml 101 112 101 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8, Cln1 </italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln5 </italic>
###xml 204 216 204 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cathepsin D </italic>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln2 </italic>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln3 </italic>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 609 614 609 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN1 </italic>
###xml 618 623 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CLN5 </italic>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 800 804 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8</italic>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 58 61 <span type="species:ncbi:10116">rat</span>
###xml 248 253 <span type="species:ncbi:9940">sheep</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 353 356 <span type="species:ncbi:10116">rat</span>
###xml 391 396 <span type="species:ncbi:10090">Mouse</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 603 608 <span type="species:ncbi:9606">human</span>
###xml 689 694 <span type="species:ncbi:9606">human</span>
The expression of several other NCL genes in mouse and/or rat has been characterized. In addition to Cln8, Cln1 and Cln5 also show developmental regulation, whereas the expression of two other NCL genes, cathepsin D underlying a naturally occuring sheep NCL model and Cln2 underlying a human late infantile-onset NCL form, is relatively constant in the rat brain during development [29-32]. Mouse Cln3 is expressed in adult mice throughout the brain, and in the hippocampus the most prominent expression is detected in the granular cell layer of the dentate gyrus and pyramidal cells [28]. In addition, human CLN1 and CLN5 genes are expressed at the beginning of neurogenesis in embryonic human brains [33]. This expression increases as brain development proceeds. Expression of NCL genes, including Cln8, in the developing and mature brain indicates that NCL proteins may have roles not only in supporting the survival of neurons but also in the maturation and differentiation of different neuronal populations during development. Defects in maturation processes could potentially lead to neuronal degeneration and loss of neurons.
###end p 25
###begin p 26
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 501 513 501 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cathepsin D </italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln1 </italic>
###xml 700 712 700 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cathepsin D </italic>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1311 1315 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd </italic>
###xml 1321 1323 1321 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1324 1326 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1379 1383 1379 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mnd </italic>
###xml 1401 1406 1401 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln1 </italic>
###xml 1410 1415 1410 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln3 </italic>
###xml 1449 1451 1449 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1452 1454 1452 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1658 1660 1658 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 637 641 <span type="species:ncbi:10116">rats</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
###xml 1425 1429 <span type="species:ncbi:10090">mice</span>
In the kindling model of experimental epilepsy a rapid up-regulation of Cln8 expression was detected in the brain, especially in hippocampal regions CA3 and the granular cell layer of the dentate gyrus. The expression of Cln8 increased at every time point measured, and was highest 24 h after kindling. Whether single or focal seizures alone are sufficient to induce Cln8 expression requires further investigation. While only Cln8 expression has been investigated in the kindling model, expression of cathepsin D and the Cln1 encoded palmitoyl protein thioesterase 1 (Ppt1) protein has been studied using kainic acid-induced seizures in rats as a model. Both show increased expression in this model, cathepsin D in the hippocampus, limbic cortex and temporo-parieto-occipital neocortex [34] and the Ppt1 protein most prominently in pyramidal cells of hippocampal regions CA1 and CA3 [35]. Although different forms of NCLs are genetically heterogenous, they share a common hippocampal pathology, which is distinct from lesions caused by anoxic-ischemic events and is instead suggested to be a consequence of primary metabolic defects [36]. Increased plasma glutamate levels, decreased glutamate uptake, descreased glutamate transporters as well as changes in ionotropic glutamate receptors has been described in mnd mice [37,38]. Also, prominent loss of GABAergic interneurons in mnd as well as in the Cln1 and Cln3 knock-out mice has been reported [39-41]. Alterations in both glutamatergic and GABAergic neurotransmission may both contribute to chronic excitotoxicity, hypothesized to underlie the cellular dysfunction and brain pathology in NCL disorders [42].
###end p 26
###begin title 27
Conclusion
###end title 27
###begin p 28
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
The Cln8 gene is widely expressed in embryonic and adult mouse tissues. In line with this, and comparable with other NCL disorders, accumulation of storage deposits in CLN8-associated disorders occurs in all tissues. However, as the most striking accumulation and cellular dysfunction is limited to neurons, it is likely that CLN8/Cln8 is involved in a neuron-specific biochemical pathway or that neuronal cells are more sensitive to accumulating material or lack compensatory pathways.
###end p 28
###begin p 29
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
The Cln8 gene is expressed throughout brain development and also in mature brain, suggesting a role for Cln8 in maturation and differentiation of neurons and in supporting the survival of neurons. The expression of Cln8 showed regional differences, suggesting a specific function for Cln8 in specific neuronal populations. The relevance of Cln8 up-regulation in hippocampal neurons of kindled mice needs to be studied further.
###end p 29
###begin title 30
Methods
###end title 30
###begin title 31
Northern blot analysis
###end title 31
###begin p 32
###xml 115 120 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 222 227 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 282 287 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 329 332 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 36 41 <span type="species:ncbi:10090">Mouse</span>
FirstChoicetrade mark Northern Blot Mouse Blot I (Ambion, Austin, TX, USA) was used to analyze the distribution of Cln8 expression in various tissues. An 872 base pair (bp) deoxyribonucleic acid (DNA) fragment including a Cln8 open reading frame of 867 bp, digested from the SvPoly-Cln8 expression vector with restriction enzyme BamHI, was used as a probe. The hybridization was performed according to the manufacturer's instructions with Ultra sensitive Hybridization buffer (Ambion), and salmon sperm DNA and Cot-1 DNA for blocking.
###end p 32
###begin title 33
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8</italic>
Real-time quantitative RT-PCR analysis of Cln8
###end title 33
###begin p 34
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 76 80 76 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 418 423 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 483 487 470 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 649 654 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 719 724 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 179 184 <span type="species:ncbi:10090">Mouse</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
Real-time quantitative RT-PCR analysis of Cln8 was performed in an ABI PRISM(R) 7000 SDS thermal cycler (Applied Biosystems, Foster City, CA, USA) using 5 mul of each tissue from Mouse Multiple Tissue cDNA (MTCtrade mark) Panel II (BD Biosciences) as template. Each 25 mul reaction contained 300 nM of reverse primer 5'-CCACTGGTTGGCCTTCCA-3' and 900 nM of forward primer 5'-GCCCTTCACCTGCATTTCC-3' as well as 200 nM of Cln8 specific probe 6FAM-TGACCACCCAGCCTTCAGGAGCAT-TAMRA in TaqMan(R) Universal PCR Master Mix (Applied Biosystems). The primers were optimized for analysis and the PCR fragment of 76 bp covered the region from 510 to 585 bp of the Cln8 open reading frame (GenBank sequence accession no AF125307). The Cln8 specific probe included a reporter dye 6-carboxyfluorescein (FAM) and a quencher dye 6-carboxy-tetramethyl-rhodamine (TAMRA). Endogenous control reactions were performed using Assays-on-Demand Mm00446973_m1 TATA-box binding protein amplification according to the manufacturer's instructions (Applied Biosystems). Each reaction was performed in triplicate. Standard complementary DNA (cDNA) solutions, generated from C57/BL mice cortex mRNA, and standard curve method were used (User Bulletin #2: ABI PRISM(R) 7700 Sequence Detection System. P/N 4303859B (2001) Applied Biosystems. 36 s.). Statistical analyses were performed using Microsoft Excel.
###end p 34
###begin p 35
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
The DNA fragment covering the whole open reading frame of Cln8 was PCR amplified using primers 3'-GTGATTTCTCCGGTGCTAGG-5' and 3'-GCAACCACCATTTCTCAGGT-5'.
###end p 35
###begin title 36
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
In situ hybridization
###end title 36
###begin p 37
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 413 415 412 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 432 437 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 679 684 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 788 790 783 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
Paraffin and cryosections of NMRI or C57/BL mice were prepared and analyzed by mRNA in situ hybridization as previously described [43-45] with slight modifications. The isolated tissues from postnatal wild-type and kindling mice were fresh-frozen and sectioned. Embryos were either fixed in 4% paraformaldehyde and embedded in paraffin or fresh-frozen and sectioned. For all serial sections of 8-14 mum, a single 35S-labeled 370 bp Cln8 specific complementary RNA (cRNA) probe (from bp 29 to 398; GeneBank AF125307) was used. For the generation of the antisense and control sense cRNAs, the vector (pBluescript vector; Stratagene, La Jolla, CA, USA) containing the PCR-amplified Cln8 fragment was linearized and used as a template for RNA polymerases T3 and T7, respectively, using alpha-35S-labeled UTP (Amersham Biosciences, Uppsala, Sweden).
###end p 37
###begin p 38
###xml 933 938 <span type="species:ncbi:4932">yeast</span>
The paraffin sections were treated as cryosections, after first being deparaffinized in xylene and rehydrated in a descending ethanol series. All the slides were fixed in 4% paraformaldehyde, rinsed twice in phosphate-buffered saline and treated with proteinase K (20 mug/ml for paraffin sections, 1 mug/ml for cryosections). Next, the slides were postfixed in 4% paraformaldehyde, and the cryosections rinsed in 50% deionized formamide in 2 x standard sodium citrate (SSC). After being washed in distilled water, all slides were acetylated for 10 minutes with 0.25% acetic anhydride in 0.1 M triethanolamine. The paraffin sections were then dehydrated in an ascending ethanol series, while the cryosections were rinsed again with 50% formamide in 2 x SSC. Prehybridization for 1 h was subsequently performed at +52degreesC with hybridization buffer containing 60% formamide, 10% dextran sulphate, 1 x Denhardt's solution, 0.5 mg/ml yeast transfer RNA (tRNA), and 100 mM dithiothreitol. After prehybridization, cRNA probes were added to the hybridization buffer at a concentration of 35 000 cpm/mul, and hybridization was carried out overnight at +52degreesC in a chamber humidified with 60% formamide and 5 x SSC.
###end p 38
###begin p 39
###xml 776 778 739 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1149 1153 <span type="species:ncbi:10090">Mice</span>
After hybridization the sections were first washed in 5 x SSC, 10 mM dithiothreitol at +50degreesC for 30 minutes, followed by 30 minutes in 50% formamide, 2 x SSC, 30 mM dithiothreitol at +65degreesC, and 3 x 10 minutes in NTE-buffer (0.5 M NaCl, 10 mM Tris-HCl, pH 8.0, 5 mM EDTA) at +37degreesC. Next, the slides were treated with RNase A (20 mug/ml) in NTE-buffer at +37degreesC for 30 min and washed for 15 min in NTE-buffer at +37degreesC. Washing with 50% formamide, 2 x SSC, 30 mM dithiothreitol was then repeated, after which the sections were washed in 2 x SSC and 0.1 x SSC, each for 15 min at +37degreesC. The slides were dehydrated at room temperature with ethanol containing 0.3 M ammonium acetate, air-dried, and exposed to BioMax MR Film (Kodak) together with 14C radioactive standards (Amersham Biosciences) for 5 days. Finally, the sections were dipped in NTB-2 emulsion (Kodak), developed after 3 to 4 weeks using D-19 developer (Kodak), fixed with Kodak Unifix, counterstained with hematoxylin (Shandon Inc./Thermoshandon, Pittsburgh, PA, USA), and mounted with Permount (Fisher Scientific International Inc., Hampton, NH, USA). Mice were bred in the Viikki Laboratory Animal Center, University of Helsinki. The experiments were conducted according to the "European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific purposes" with the approval of the institutional ethics committee.
###end p 39
###begin title 40
Rapid kindling procedure
###end title 40
###begin p 41
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 910 912 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 938 940 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1305 1313 1303 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1590 1598 1588 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 1369 1373 <span type="species:ncbi:10090">mice</span>
Adult male C57/BL mice weighing 22-25 g (n = 16) were anaesthetized with sodium pentobarbital (60 mg/kg i.p.), and bipolar stainless steel electrodes (Plastics One) were implanted in the left ventral hippocampus using a Kopf stereotaxic frame as previously described [46]. One week later, the mice were electrically stimulated with forty threshold stimulations with 5 min intervals (10 Hz frequency, 1 ms square-wave pulses for 10 s). The electroencephalogram was continuously recorded during the whole rapid kindling procedure using the MacLab/4e system (ADInstruments). To determine the threshold, current intensity was increased stepwise (10 muA increments, starting from 10 muA) every 5 min until focal epileptiform activity (afterdischarge) of at least 5 s duration was elicited. Rapid kindling stimulations were then given on the same day. Behavioral convulsions were scored according to a modification [25] of the scale of Racine [47]: grade 0, arrest, normal behavior; grade 1, facial twitches; grade 2, chewing and nodding; grade 3, forelimb clonus; grade 4, rearing, body jerks, tail upholding; and grade 5, imbalance, hind-limb clonus and vocalization. At 2, 6 and 24 h after the last stimulus-evoked seizure, animals were decapitated (four animals in each group) and brains were processed for in situ hybridization. Four non-stimulated, electrode-implanted mice served as controls and were killed together with the experimental animals from different groups. The correct localization of the electrode was controlled for each animal in the coronal sections of the brain used for in situ hybridization. All experimental procedures were approved by the Research Ethics Committee at the Medical Faculty of the University of Lund.
###end p 41
###begin title 42
Quantitative and statistical analysis
###end title 42
###begin p 43
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 183 185 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
Quantification of radioactive in situ hybridization films was done by digitizing the film images with a computer-based MCID image analysis system (Imaging Research). Gray levels from 14C radioactive standards were used in a third-degree polynomial calibration to obtain equivalent values of tissue radioactivity (nCi/g) for different brain regions. Measurements for each structure were carried out in several sections per animal. Since there were no significant differences between the two sides, values were pooled to obtain the mean value for each animal and brain region. Data from four control and four experimental animals for every probe and time point were used for analysis. Statistical analysis was performed using Student's t-tests. In the figures, the densities of hybridization signals of sense and antisense probes are shown separately. Sense values were not subtracted from antisense values because of different probes used. Error bars represent standard error of the mean; symbols *, ** and *** represent p < 0.05, 0.01 and 0.001, respectively.
###end p 43
###begin title 44
Authors' contributions
###end title 44
###begin p 45
###xml 123 131 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 233 241 233 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 632 640 632 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 315 320 <span type="species:ncbi:10090">mouse</span>
LL carried out real-time quantitative PCR and northern blot analyses. In addition, LL was involved in the analysis of mRNA in situ results and design of the study, drafted the manuscript and made the figures. AA carried out the mRNA in situ analysis and was involved in drafting the manuscript. OK prepared several mouse tissue samples for the mRNA in situ analysis, was involved in the analysis of the mRNA in situ results, and revised the manuscript. MK established the real-time quantitative RT-PCR methodology and helped with the analysis. ZK provided all kindling samples and contributed significantly to figures 3 and 4. mRNA in situ analyses were conducted under the supervision of MS, who also revised the manuscript and was involved in the design of the study. AEL was involved in the design of the study, analysis of the results and revision of the manuscript.
###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
###xml 214 222 214 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 338 346 338 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
We thank Teija-Tuulia Toivonen and Eila Kujamaki for technical assistance as well as Tarja Salonen and Tarja Joensuu for advice and support. Susanna Ranta is thanked for cloning and testing constructs for the mRNA in situ hybridization analysis. Pertti Panula and Oleg Anichtch are thanked for help in the quantification analysis of mRNA in situ hybridization and Matthew Phillips and Jodie Painter for critical reading of the manuscript. This work has been supported by the Academy of Finland Centre of Excellence in Disease Genetics, project 44870 Finnish Centre of Excellence programme 2000-2005, Sigrid Juselius Foundation, Folkhalsan Research Foundation and Swedish Research Council. The Lund Stem Cell Center is supported by a Center of Excellence grant in life sciences from the Swedish Foundation for Strategic Research. Liina Lonka is a student at the Helsinki Graduate School in Biotechnology and Molecular Biology, University of Helsinki.
###end p 47
###begin article-title 48
Neuronal ceroid-lipofuscinoses in childhood
###end article-title 48
###begin article-title 49
The neuronal ceroid-lipofuscinoses
###end article-title 49
###begin article-title 50
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9
###end article-title 50
###begin article-title 51
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8
###end article-title 51
###begin article-title 52
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Autosomal dominance in a late-onset motor neuron disease in the mouse
###end article-title 52
###begin article-title 53
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice
###end article-title 53
###begin article-title 54
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse gene knockout model for juvenile ceroid-lipofuscinosis (Batten disease)
###end article-title 54
###begin article-title 55
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 91 96 <span type="species:ncbi:10090">Mouse</span>
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]
###end article-title 55
###begin article-title 56
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth
###end article-title 56
###begin article-title 57
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons
###end article-title 57
###begin article-title 58
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum
###end article-title 58
###begin article-title 59
Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells
###end article-title 59
###begin article-title 60
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy
###end article-title 60
###begin article-title 61
Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration
###end article-title 61
###begin article-title 62
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 31 37 <span type="species:ncbi:9103">Turkey</span>
Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies
###end article-title 62
###begin article-title 63
Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis
###end article-title 63
###begin article-title 64
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouse
###end article-title 64
###begin article-title 65
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Retinal degeneration in motor neuron degeneration (mnd) mutant mice
###end article-title 65
###begin article-title 66
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
Accumulating autofluorescent material as a marker for early changes in the spinal cord of the Mnd mouse
###end article-title 66
###begin article-title 67
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)
###end article-title 67
###begin article-title 68
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Neurofilament distribution is altered in the Mnd (motor neuron degeneration) mouse
###end article-title 68
###begin article-title 69
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Cytoplasmic inclusions in spinal neurons of the motor neuron degeneration (Mnd) mouse. I. Light microscopic analysis
###end article-title 69
###begin article-title 70
A permanent change in brain function resulting from daily electrical stimulation
###end article-title 70
###begin article-title 71
Persistence of kindling: effect of partial kindling, retention interval, kindling site, and stimulation parameters
###end article-title 71
###begin article-title 72
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Generalization of rapidly recurring seizures is suppressed in mice lacking glial cell line-derived neurotrophic factor family receptor alpha2
###end article-title 72
###begin article-title 73
Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL)
###end article-title 73
###begin article-title 74
CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease
###end article-title 74
###begin article-title 75
The expression of palmitoyl-protein thioesterase is developmentally regulated in neural tissues but not in nonneural tissues
###end article-title 75
###begin article-title 76
###xml 135 138 <span type="species:ncbi:10116">rat</span>
Palmitoyl-protein thioesterase, an enzyme implicated in neurodegeneration, is localized in neurons and is developmentally regulated in rat brain
###end article-title 76
###begin article-title 77
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Developmental expression of palmitoyl protein thioesterase in normal mice
###end article-title 77
###begin article-title 78
A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration
###end article-title 78
###begin article-title 79
###xml 127 132 <span type="species:ncbi:9606">human</span>
CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain
###end article-title 79
###begin article-title 80
###xml 50 53 <span type="species:ncbi:10116">rat</span>
Elevated cathepsin D expression in kainate-evoked rat brain neurodegeneration
###end article-title 80
###begin article-title 81
Status epilepticus induces changes in the expression and localization of endogenous palmitoyl-protein thioesterase 1
###end article-title 81
###begin article-title 82
Hippocampal lesions in the neuronal ceroid lipofuscinoses
###end article-title 82
###begin article-title 83
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (Mnd) mice
###end article-title 83
###begin article-title 84
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder
###end article-title 84
###begin article-title 85
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment
###end article-title 85
###begin article-title 86
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis
###end article-title 86
###begin article-title 87
Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis
###end article-title 87
###begin article-title 88
Regulation of the mitochondrial ATP-synthase in health and disease
###end article-title 88
###begin article-title 89
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Expression of mRNAs for neurotrophins and their receptors in developing rat heart
###end article-title 89
###begin article-title 90
###xml 90 93 <span type="species:ncbi:10116">rat</span>
GDNF family ligands and receptors are differentially regulated after brain insults in the rat
###end article-title 90
###begin article-title 91
Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems
###end article-title 91
###begin article-title 92
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor alpha 2
###end article-title 92
###begin article-title 93
Modification of seizure activity by electrical stimulation. II. Motor seizure
###end article-title 93
###begin title 94
Figures and Tables
###end title 94
###begin p 95
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Northern blot and RT-PCR analysis of <italic>Cln8 </italic>mRNA expression in mouse tissues </bold>
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 233 234 230 231 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 278 283 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 319 324 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 395 400 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
Northern blot and RT-PCR analysis of Cln8 mRNA expression in mouse tissues A: Northern blot analysis of Cln8 transcripts in mouse tissues. A beta-actin probe was used as a control. Molecular weight marker in kb is shown on the left. B: Real-time quantitative RT-PCR analysis of Cln8 in mouse tissues. The expression of Cln8 in brain, given a value of 1, was used as a control. The expression of Cln8 in the other tissues is shown as a fold of the control.
###end p 95
###begin p 96
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In situ </italic>hybridization analysis of <italic>Cln8 </italic>mRNA expression in mouse embryos. </bold>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
In situ hybridization analysis of Cln8 mRNA expression in mouse embryos. In the E17 mouse embryo, developing gastrointestinal tract (A, B) and DRG (C, D), hybridized with Cln8 specific cRNA probe, are shown. Bright-field view of the cells is shown on the left (A, C) and dark-field detection of hybridization signals on the right (B,D). Optical density values of hybridization signals of Cln8 sense and antisense probes in E13 and E17 gut and brain tissues are shown in the diagram (E). Error bars represent standard error of the mean. s = sense, as = antisense
###end p 96
###begin p 97
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Differential distribution of <italic>Cln8 </italic>mRNA in brains of P0, P5, P10 and adult mouse. </bold>
###xml 176 184 176 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Differential distribution of Cln8 mRNA in brains of P0, P5, P10 and adult mouse. Dark-field emulsion autoradiographs from frontal sections, shown on the left, were analyzed by in situ hybridization analysis (A-D). Higher magnification in the hippocampal area CA3 is shown on the right. Bright-field views of the cells (a-d) and dark-field emulsion autoradiographs (a'-d') are shown. Optical density values of hybridization signals of Cln8 antisense probe are shown as bars in the diagram below (A = adult). Optical density values of hybridization signals of Cln8 sense probe are shown as a gray area behind the bars. In each brain region the optical density values at P0, P5 and P10 were compared to the optical density value of adult. Error bars represent standard error of the mean. Symbols *, ** and *** represent p < 0.05, 0.01 and 0.001, respectively. CX = cortex, DG = dentate gyrus
###end p 97
###begin p 98
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distribution of <italic>Cln8 </italic>mRNA in brains of hippocampal kindling induced epileptic mice. </bold>
###xml 190 198 190 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cln8 </italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 213 217 <span type="species:ncbi:10090">Mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
Distribution of Cln8 mRNA in brains of hippocampal kindling induced epileptic mice. Frontal mouse brain sections were analyzed 2 h, 6 h and 24 h after kindling induced epileptic seizures by in situ hybridization. Mice with electrodes implanted but without electrical stimulations were used as controls (0 h). Dark-field emulsion autoradiographs of hippocampal Cln8 expression in kindling-induced mice 0 h and 24 h after kindling are shown. Optical density values of hybridization signals of Cln8 antisense probe are shown as bars in the diagram. Optical density values of hybridization signals of Cln8 sense probe are shown as a gray area behind the bars. In each brain region the optical density values 2 h, 6 h and 24 h after kidling-induced seizures were compared to controls (0 h). Error bars represent standard error of the mean. Symbols *, ** and *** represent p < 0.05, 0.01 and 0.001, respectively. DG = dentate gyrus
###end p 98

